NCT03119480

Brief Summary

To set up electronic early warning system of AKI patients; To develop AKI's intervention, the follow-up process, and the renal physician is responsible for the implementation. To Observe the method after implementing the treatment efficacy of AKI and the differences between the traditional treatment process.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 18, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

October 15, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2018

Completed
Last Updated

October 17, 2018

Status Verified

October 1, 2018

Enrollment Period

1 year

First QC Date

April 13, 2017

Last Update Submit

October 16, 2018

Conditions

Acute Kidney Injury

Keywords

Acute Kidney InjuryElectronic alerts

Outcome Measures

Primary Outcomes (1)

  • all-cause mortality

    death at 7 days after alert

    at 7 days after alert

Secondary Outcomes (2)

  • dialysis

    at 7 days after alert

  • change in creatinine

    at 7 days after alert

Study Arms (1)

Hospital-acquired AKI

Adult patients with Hospital-acquired AKI

Device: electronic alerts

Interventions

electronic alertsDEVICE

electronic alerts for AKI

Hospital-acquired AKI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

adult patients aged\>18 years,with hospital-acquired acute kidney injury, from a university-affiliated hospital in Shanghai, China

You may qualify if:

  • Eligible participants were adults aged 18 years or older who were in hospital with stage 1 or greater acute kidney injury as defined by Kidney Disease Improving Global Outcomes creatinine-based criteria.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Ninth People's Hospital

Shanghai, Shanghai Municipality, 200011, China

Location

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Feng Ding, PhD

    Division of Nephrology,Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Kidney internal medicine professor

Study Record Dates

First Submitted

April 13, 2017

First Posted

April 18, 2017

Study Start

October 15, 2017

Primary Completion

October 15, 2018

Study Completion

October 15, 2018

Last Updated

October 17, 2018

Record last verified: 2018-10

Locations

CN(1)